Navigation Links
Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
Date:7/25/2013

es," said Dr. Beyer.  "I am honored to join this unique team and to lead the company's drug discovery efforts closer to patients and their families."

Shortly after beginning his research career at the National Institutes of Health (NIH) in NIDA's Addiction Research Center, Dr. Beyer earned his Ph.D. in Pharmacology from Louisiana State University Medical Center and an MBA from the Rutgers School of Business.  He has authored more than 70 manuscripts, been granted three patents, is an editor of Next Generation Antidepressants, a psychiatry review book, and is co-founder of the journal Technology Transfer & Entrepreneurship.  Dr. Beyer also serves as an adjunct faculty member at Thomas Jefferson University where he teaches Bioventure Management.

About Promentis Pharmaceuticals, Inc:
Promentis Pharmaceuticals, Inc. was founded in 2007 and is a private, emerging pharmaceutical company focused on developing unique compounds aimed at modifying brain chemistry for the treatment of schizophrenia and other central nervous system disorders.  Support for Promentis' drug discovery and development programs, in part, is provided by recent grants from the National Institute of Mental Health (NIMH) and the Michael J. Fox Foundation.  Additional information can be found at www.promentispharma.com.

Media Contact:
Tiberend Strategic Advisors, Inc.
(212) 375-2694
Andrew Mielach
amielach@tiberend.com


'/>"/>
SOURCE Promentis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
4. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
5. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
6. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
7. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
8. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
10. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
11. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Israel , June 29, 2015 ... today announced positive preliminary results from its BVX-006 Phase ... universal influenza vaccine. In this trial, M-001 was injected ... 65, followed by an administration of the 2014/15 season ... found to be safe and well tolerated and induced ...
(Date:6/29/2015)... , June 29, 2015 Regeneron ... that the Proceedings of the National Academy ... demonstrating that the Company,s proprietary VelociGene ® ... identification and preclinical validation of potential candidates that ... of Middle East Respiratory Syndrome (MERS). This involved ...
(Date:6/29/2015)... , June 29, 2015 The global ... by 2020, according to a new study by Grand View Research, ... and the presence of high unmet needs in emerging markets such ... are expected to be two of the most significant growth ... diseases such as obesity and growing global geriatric population base are ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4
... 2011 Merrimack Pharmaceuticals, Inc. announced today that ... randomized Phase 2 clinical trial of MM-121, a ... with paclitaxel (Taxol®) in the neoadjuvant setting of ... The Phase 2 study is designed ...
... Calif., Oct. 11, 2011 Codexis, Inc. (Nasdaq: ... has been named Director, Latin America. He will head ... for managing Codexis, expanding role in Latin America. He ... and SVP, Process Development and Manufacturing. ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients 2Codexis Names Veteran Chemical Executive to Lead Codexis do Brasil 2Codexis Names Veteran Chemical Executive to Lead Codexis do Brasil 3
(Date:6/29/2015)... ... June 30, 2015 , ... Leaders ... one of the industry’s premier thought leadership symposiums, “Harmony 2015” hosted by Massachusetts-based ... rehabilitation managers and other management and corporate personnel representing the skilled nursing and ...
(Date:6/29/2015)... ... June 30, 2015 , ... The United States Equestrian ... (KORT) as it becomes the Official Physical and Occupational Therapists of the U.S. Eventing ... Kentucky Three-Day Event presented by Land Rover. , “The USEF is pleased to ...
(Date:6/29/2015)... ... June 30, 2015 , ... With thousands of children in ... in a much-needed autism support center, planned at Utah Valley University, in Orem, Utah. ... for the center and the building in which it will be housed. , Utah ...
(Date:6/29/2015)... (PRWEB) , ... June 30, 2015 , ... ... training, has released a new website intended for executives and administrators with hospitals, ... user experience, and the final product is a result of comprehensive research and ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... to educate readers and potential patients about a variety of plastic surgery and ... dentistry and more. , It has been the main focus of Cosmetic Town ...
Breaking Medicine News(10 mins):Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 3Health News:Career Step Launches New Website to Better Meet Needs of Partners, Clients and Others Searching for Corporate Training Solutions 2Health News:Board of Advisors Now Coming to Cosmetic Town 2
... that exposure to a chemical called diacetyl, a component ... nose and airways of mice. Scientists at the National ... National Institutes of Health, conducted the study because diacetyl ... humans. OB is a debilitating but rare lung disease, ...
... University of Leicester has been able to establish for ... may have miscarriages and those who wont. Their research ... American Medical Association. , The researchers measured the levels ... anandamide in women who presented with a threatened miscarriage ...
... For accuracy,s sake, medical professionals should use the ... images taken from different time periods and laboratories, ... collaborative study, published in the January-February issue of ... researchers at Sacred Heart Medical Center in Eugene, ...
... mimicked a tumor of the pancreas and the diagnosis was ... pancreatectomy. , This report performed by a team led by ... to be published in Volume 14 issue 6 of the ... age of patient, and on the localization, size and shape ...
... Insurers Strengthens its ... Patients, BERKELEY HEIGHTS, N.J., March 13 ... provider of secure workflow,management software and web-based services, ... leading mobility benefit providers to,national and regional insurers ...
... America Launches ,Treat It, Don,t Repeat ... Educational Campaign -, WASHINGTON, March 13 More ... their condition has,a negative impact on important relationships -- ... to a new national survey commissioned by the,Anxiety Disorders ...
Cached Medicine News:Health News:Rodent study finds artificial butter chemical harmful to lungs 2Health News:Leicester medical team announces 'predictor' for pregnant women who may have miscarriages 2Health News:Leicester medical team announces 'predictor' for pregnant women who may have miscarriages 3Health News:Researchers make case for standardized analysis of cardiac imaging 2Health News:Wheelchair Professionals Selects Authentidate's Inscrybe Healthcare Platform to Streamline Mobility Order Processing 2Health News:Wheelchair Professionals Selects Authentidate's Inscrybe Healthcare Platform to Streamline Mobility Order Processing 3Health News:Wheelchair Professionals Selects Authentidate's Inscrybe Healthcare Platform to Streamline Mobility Order Processing 4Health News:Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life 2Health News:Video: New Survey Reveals More Than Half of Adults With OCD Say the Disorder Has a Negative Impact on Relationships at Home, Work and in Their Personal Life 3
For regulating sample flow rate when using the QIAvac 24 Plus;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 8-multi channels...
... Filter Units,Filter units with hydrophobic PTFE ... membrane are ideal for the sterilizing ... sterile containers, and for sterilizing or ... mm Millex filter units are available ...
Medicine Products: